021-51111890
购物车（）
sales@molnova.cn
Targocil
CAS No. 1200443-21-5
Targocil ( —— )
产品货号. M17185 CAS No. 1200443-21-5
Targocil is used as a bacteriostatic inhibitor of wall teichoic acid (WTA) biosynthesis which can inhibit the growth of methicillin-susceptible S. aureus (MSSA) and methicillin-resistant S. aureus (MRSA) (MIC90s: 2 μg/ mL) for both MRSA and MSSA.
纯度: 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ￥648 | 有现货 |
|
| 5MG | ￥1158 | 有现货 |
|
| 10MG | ￥1742 | 有现货 |
|
| 25MG | ￥3127 | 有现货 |
|
| 50MG | ￥4641 | 有现货 |
|
| 100MG | ￥6658 | 有现货 |
|
| 200MG | ￥9153 | 有现货 |
|
| 500MG | ￥13689 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Targocil
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述Targocil is used as a bacteriostatic inhibitor of wall teichoic acid (WTA) biosynthesis which can inhibit the growth of methicillin-susceptible S. aureus (MSSA) and methicillin-resistant S. aureus (MRSA) (MIC90s: 2 μg/ mL) for both MRSA and MSSA.
-
产品描述Targocil is used as a bacteriostatic inhibitor of wall teichoic acid (WTA) biosynthesis which can inhibit the growth of methicillin-susceptible S. aureus (MSSA) and methicillin-resistant S. aureus (MRSA) (MIC90s: 2 μg/ mL) for both MRSA and MSSA.
-
同义词——
-
通路Endocrinology/Hormones
-
靶点5-HT Receptor
-
受体Others
-
研究领域Infection
-
适应症——
化学信息
-
CAS Number1200443-21-5
-
分子量475.95
-
分子式C21H22ClN5O4S
-
纯度98%
-
溶解度DMSO : 33.33 mg/mL. 70.03 mM; H2O : < 0.1 mg/mL
-
SMILESCCN(CC)c1nc2c(nnn2c2cc(c(cc12)OC)OC)S(=O)(=O)c1ccc(cc1)Cl
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Suzuki T, et al. In vitro antimicrobial activity of wall teichoic acid biosynthesis inhibitors against Staphylococcus aureus isolates. Antimicrob Agents Chemother. 2011 Feb;55(2):767-74.
产品手册
关联产品
-
Ziprasidone
A full antagonist of D2 and 5-HT2A receptors with Ki of 6.8 and 0.6 nM, respectively; also is a partial agonist of 5-HT1A, and a partial antagonist of 5-HT2C and 5-HT1D receptors.
-
Sarpogrelate hydroch...
A potent, specific 5HT2 receptor antagonist with Ki of 8.39 nM for 5-HT2A; also shows binding affinity for 5-HT2B.
-
Ziprasidone hydrochl...
A full antagonist of D2 and 5-HT2A receptors with Ki of 6.8 and 0.6 nM, respectively; also is a partial agonist of 5-HT1A, and a partial antagonist of 5-HT2C and 5-HT1D receptors.
